Cholangiocyte organoids for disease, cancer, and regenerative medicine

The biliary tract is a ductal network comprising the intrahepatic (IHBDs) and extrahepatic bile duct (EHBDs). Biliary duct disorders include cholangitis, neoplasms, and injury. However, the underlying mechanisms are not fully understood. With advancements in 3D culture technology, cholangiocyte orga...

Full description

Saved in:
Bibliographic Details
Main Authors: Munemasa Nagao, Akihisa Fukuda, Hirotaka Kashima, Sho Matsuyama, Kei Iimori, Shinnosuke Nakayama, Kenta Mizukoshi, Munenori Kawai, Go Yamakawa, Mayuki Omatsu, Mio Namikawa, Tomonori Masuda, Yukiko Hiramatsu, Yu Muta, Takahisa Maruno, Yuki Nakanishi, Tatsuaki Tsuruyama, Hiroshi Seno
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:European Journal of Cell Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S017193352400089X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590957857472512
author Munemasa Nagao
Akihisa Fukuda
Hirotaka Kashima
Sho Matsuyama
Kei Iimori
Shinnosuke Nakayama
Kenta Mizukoshi
Munenori Kawai
Go Yamakawa
Mayuki Omatsu
Mio Namikawa
Tomonori Masuda
Yukiko Hiramatsu
Yu Muta
Takahisa Maruno
Yuki Nakanishi
Tatsuaki Tsuruyama
Hiroshi Seno
author_facet Munemasa Nagao
Akihisa Fukuda
Hirotaka Kashima
Sho Matsuyama
Kei Iimori
Shinnosuke Nakayama
Kenta Mizukoshi
Munenori Kawai
Go Yamakawa
Mayuki Omatsu
Mio Namikawa
Tomonori Masuda
Yukiko Hiramatsu
Yu Muta
Takahisa Maruno
Yuki Nakanishi
Tatsuaki Tsuruyama
Hiroshi Seno
author_sort Munemasa Nagao
collection DOAJ
description The biliary tract is a ductal network comprising the intrahepatic (IHBDs) and extrahepatic bile duct (EHBDs). Biliary duct disorders include cholangitis, neoplasms, and injury. However, the underlying mechanisms are not fully understood. With advancements in 3D culture technology, cholangiocyte organoids (COs) derived from primary tissues or induced pluripotent stem cells (iPSCs) can accurately replicate the structural and functional properties of biliary tissues. These organoids have become powerful tools for studying the pathogenesis of biliary diseases, such as cystic fibrosis and primary sclerosing cholangitis, and for developing new therapeutic strategies for cholangiocarcinoma. Additionally, COs have the potential to repair bile duct injuries and facilitate transplantation therapies. This review also discusses the use of organoids in genetically engineered mouse models to provide mechanistic insights into tumorigenesis and cancer progression. Continued innovation and standardization of organoid technology are crucial for advancing precision medicine for biliary diseases and cancer.
format Article
id doaj-art-630d0d9852334301ae3518510e863aa9
institution Kabale University
issn 0171-9335
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series European Journal of Cell Biology
spelling doaj-art-630d0d9852334301ae3518510e863aa92025-01-23T05:26:15ZengElsevierEuropean Journal of Cell Biology0171-93352025-03-011041151472Cholangiocyte organoids for disease, cancer, and regenerative medicineMunemasa Nagao0Akihisa Fukuda1Hirotaka Kashima2Sho Matsuyama3Kei Iimori4Shinnosuke Nakayama5Kenta Mizukoshi6Munenori Kawai7Go Yamakawa8Mayuki Omatsu9Mio Namikawa10Tomonori Masuda11Yukiko Hiramatsu12Yu Muta13Takahisa Maruno14Yuki Nakanishi15Tatsuaki Tsuruyama16Hiroshi Seno17Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan; Corresponding author.Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan; Department of Gastroenterology and Hepatology, The Japan Baptist Hospital, 47 Yamanomoto-cho, Kitashirakawa, Sakyo-ku, Kyoto 606-8273, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, JapanDepartment of Discovery Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, JapanDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, JapanThe biliary tract is a ductal network comprising the intrahepatic (IHBDs) and extrahepatic bile duct (EHBDs). Biliary duct disorders include cholangitis, neoplasms, and injury. However, the underlying mechanisms are not fully understood. With advancements in 3D culture technology, cholangiocyte organoids (COs) derived from primary tissues or induced pluripotent stem cells (iPSCs) can accurately replicate the structural and functional properties of biliary tissues. These organoids have become powerful tools for studying the pathogenesis of biliary diseases, such as cystic fibrosis and primary sclerosing cholangitis, and for developing new therapeutic strategies for cholangiocarcinoma. Additionally, COs have the potential to repair bile duct injuries and facilitate transplantation therapies. This review also discusses the use of organoids in genetically engineered mouse models to provide mechanistic insights into tumorigenesis and cancer progression. Continued innovation and standardization of organoid technology are crucial for advancing precision medicine for biliary diseases and cancer.http://www.sciencedirect.com/science/article/pii/S017193352400089XCholangiocyte organoidCholangiocarcinomaBiliary cancerOrganoid
spellingShingle Munemasa Nagao
Akihisa Fukuda
Hirotaka Kashima
Sho Matsuyama
Kei Iimori
Shinnosuke Nakayama
Kenta Mizukoshi
Munenori Kawai
Go Yamakawa
Mayuki Omatsu
Mio Namikawa
Tomonori Masuda
Yukiko Hiramatsu
Yu Muta
Takahisa Maruno
Yuki Nakanishi
Tatsuaki Tsuruyama
Hiroshi Seno
Cholangiocyte organoids for disease, cancer, and regenerative medicine
European Journal of Cell Biology
Cholangiocyte organoid
Cholangiocarcinoma
Biliary cancer
Organoid
title Cholangiocyte organoids for disease, cancer, and regenerative medicine
title_full Cholangiocyte organoids for disease, cancer, and regenerative medicine
title_fullStr Cholangiocyte organoids for disease, cancer, and regenerative medicine
title_full_unstemmed Cholangiocyte organoids for disease, cancer, and regenerative medicine
title_short Cholangiocyte organoids for disease, cancer, and regenerative medicine
title_sort cholangiocyte organoids for disease cancer and regenerative medicine
topic Cholangiocyte organoid
Cholangiocarcinoma
Biliary cancer
Organoid
url http://www.sciencedirect.com/science/article/pii/S017193352400089X
work_keys_str_mv AT munemasanagao cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT akihisafukuda cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT hirotakakashima cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT shomatsuyama cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT keiiimori cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT shinnosukenakayama cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT kentamizukoshi cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT munenorikawai cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT goyamakawa cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT mayukiomatsu cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT mionamikawa cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT tomonorimasuda cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT yukikohiramatsu cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT yumuta cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT takahisamaruno cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT yukinakanishi cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT tatsuakitsuruyama cholangiocyteorganoidsfordiseasecancerandregenerativemedicine
AT hiroshiseno cholangiocyteorganoidsfordiseasecancerandregenerativemedicine